Buyer Snapshot
- Best-fit buyer
- Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
- Primary use case
- Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
- Typical deployment
- Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow
What to Verify
Evidence
- Was the tool tested prospectively and independently on comparable equipment and patients?
- What are sensitivity, specificity, false positive workload, and time-to-action effects?
- How does performance vary by site, scanner, demographic subgroup, and disease prevalence?
Regulatory and workflow
- Which FDA authorization covers the exact product version, modality, and intended use?
- Who retains final clinical responsibility and how is disagreement with the AI handled?
- What post-deployment monitoring and material update notification does the vendor provide?
Data and contracts
- Where are images and derived data processed and retained?
- Which PACS, RIS, pathology, and EHR integrations are supported in production?
- Can data be used for model improvement, and what controls govern secondary use?
FDA Clearances on Record
Viz.ai appears on 8 cleared products in the federal 510(k) record, across 3 device types.
- AI Triage and Notification Software for Radiology ... 5 cleared products
- AI Lesion Prioritization Software for Radiology ... 2 cleared products
- Cardiovascular Machine Learning Notification Software ... 1 cleared product
A clearance means the FDA agreed the product is close enough to something already on the market to be sold for that use. It is not a finding that the product helps patients, and it is not a ranking against anything else on this page. A company is linked to an FDA clearance only when the 510(k) applicant name on the government record is confirmed by hand to be that same company, including former corporate names. Name similarity alone is never enough, and rejected matches are listed below with the reason.
What the Published Research Says
Before a demo, it helps to know what independent studies found about this kind of work generally, separate from any one company's own results.
- AI Stroke Triage ... 24 studies
- AI in Breast Cancer Screening ... 24 studies
- AI in Digital Pathology ... 24 studies